Related Experiment Video
Updated: Jun 29, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Characteristics and outcomes of cerebral venous thrombosis associated with COVID-19
Adrian Scutelnic1, Anita van de Munckhof2, Angel T Miraclin3
1Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Insights
Patients with coronavirus disease 2019 associated cerebral venous thrombosis (COVID-CVT) showed similar mortality and functional outcomes compared to pre-pandemic controls. This international study found no significant difference in outcomes for COVID-CVT patients.
Area of Science:
- Neurology
- Infectious Diseases
- Vascular Medicine
Background:
- Previous reports on COVID-19 associated cerebral venous thrombosis (COVID-CVT) suggested high mortality rates (up to 40%) based on small case series.
- The clinical characteristics and outcomes of COVID-CVT require further investigation in larger, international cohorts.
Purpose of the Study:
- To assess the clinical characteristics and outcomes of an international cohort of patients with COVID-CVT.
- To compare the outcomes of COVID-CVT patients with a historical control group of cerebral venous thrombosis (CVT) patients.
Main Methods:
- A registry study of consecutive COVID-CVT patients diagnosed between March 2020 and March 2023.
- Utilized data from the International Cerebral Venous Thrombosis Consortium for comparison, including patients with CVT diagnosed between 2017 and 2018.
- Outcome analyses were adjusted for age and sex.
Main Results:
- Included 70 COVID-CVT patients from 23 hospitals in 15 countries and 206 controls.
- COVID-CVT patients presented more frequently with altered mental state (44% vs 25%) and had a longer hospital stay (11 vs 8 days).
- In-hospital mortality (7% vs 3%) and functional independence at 6 months (78% vs 87%) did not significantly differ between groups.
Conclusions:
- Contrary to prior small studies, this international cohort found no significant difference in in-hospital mortality between COVID-CVT patients and pre-COVID-19 controls.
- Functional outcomes at 6-month follow-up were also comparable between the COVID-CVT group and the historical control group.
Introduction:
Previous reports and meta-analyses derived from small case series reported a mortality rate of up to 40% in patients with coronavirus disease 2019 associated cerebral venous thrombosis (COVID-CVT). We assessed the clinical characteristics and outcomes in an international cohort of patients with COVID-CVT.
Patients And Methods:
This was a registry study of consecutive COVID-CVT patients diagnosed between March 2020 and March 2023. Data collected by the International Cerebral Venous Thrombosis Consortium from patients with CVT diagnosed between 2017 and 2018 served as a comparison. Outcome analyses were adjusted for age and sex.
Results:
We included 70 patients with COVID-CVT from 23 hospitals in 15 countries and 206 controls from 14 hospitals in 13 countries. The proportion of women was smaller in the COVID-CVT group (50% vs 68%, p < 0.01). A higher proportion of COVID-CVT patients presented with altered mental state (44% vs 25%, p < 0.01), the median thrombus load was higher in COVID-CVT patients (3 [IQR 2-4] vs 2 [1-3], p < 0.01) and the length of hospital stay was longer compared to controls (11 days [IQR 7-20] vs 8 [4-15], p = 0.02). In-hospital mortality did not differ (5/67 [7%, 95% CI 3-16] vs 7/206 [3%, 2-7], aOR 2.6 [95% CI 0.7-9]), nor did the frequency of functional independence after 6 months (modified Rankin Scale 0-2; 45/58 [78%, 95% CI 65-86] vs 161/185 [87%, 81-91], aOR 0.5 [95% CI 0.2-1.02]).
Conclusion:
In contrast to previous studies, the in-hospital mortality rate and functional outcomes during follow-up did not differ between COVID-CVT patients and the pre-COVID-19 controls.
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Veins of Head and Neck
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Pneumonia III: Complications and Assessment
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...

